DR RAHUL PURWAR
Laurus Labs to buy 26% in CAR T-cell therapy companyFounded in 2018 by Dr Rahul Purwar and a team of scientists, ImmunoACT is collaborating with institutions like Tata Memorial Hospital. Carl...20 Nov, 2021, 12.26 AM IST
Laurus Labs acquires stake in IIT-Bombay incubated CAR-T cell therapy companyAs per the agreement, Laurus will acquire 26.62% stake (fully diluted basis) for a cash consideration of approximately Rs 46 crores, subjec...19 Nov, 2021, 06.26 PM IST
Load More